ArticleAlimentary pharmacology & therapeutics2022

Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis.

Mark D Muthiah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.